Medicines List

Select category
  • Description

    Ivabenor contains ivabradine. It mainly works by reducing the heart rate by a few beats per minute. This lowers the heart’s need for oxygen especially in situations when an angina attack is more likely to happen. Ivabenor thereby helps to control and reduce the number of angina attacks.

    Indications

    Symptomatic treatment of chronic stable angina pectoris
    Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease in adults with normal sinus rhythm and heart rate ≥ 70 bpm.
    Ivabradine is indicated:
    – in adults unable to tolerate or with a contraindication to the use of beta-blockers;
    – in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.

    Treatment of chronic heart failure
    Ivabradine is indicated in chronic heart failure II to IV class (according to NYHA classification) with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 5 mg, 7.5 mg film-coated tablets

  • Description

    Coolsart is a combination of an angiotensin II receptor antagonist with olmesartan medoxomil and a thiazide diuretic – hydrochlorothiazide. The combination of these ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone.

    Indications

    Coolsart 20 mg/12.5 mg film-coated tablets
    – treatment of essential hypertension;
    – olmesartan medoxomil/hydrochlorothiazide 20 mg/12.5 mg fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil alone.

    Coolsart 40 mg/12.5 mg film-coated tablets
    – treatment of essential hypertension;
    – olmesartan/hydrochlorothiazide 40 mg/12.5 mg fixed-dose combinations is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil 40 mg alone.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 20 mg/12.5 mg; 40 mg/12.5 mg film-coated tablets

  • Description

    Bilamcar combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: an angiotensin II receptor antagonist, candesartan cilexetil and a dihydropyridinic calcium channel blocker, amlodipine. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

    Indications

    Bilamcar is indicated for treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is already adequately controlled with the individual components given concurrently at the same dose levels as in the fixed combination, but as separate medicines.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 8 mg/5 mg, 8 mg/10 mg, 16 mg/5 mg, 16 mg/10 mg hard capsules

  • Description

    Pizona Combi contains pioglitazone and metformin.
    Pizona Combi helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.

    Indications

    Pizona Combi is indicated as second line treatment of type 2 diabetes mellitus in adult patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 15 mg/ 850 mg film-coated tablets